Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials!!

Clinical Trial 15677

tamarac, fl 33319


Study Summary:

A randomized, double-blind, placebo-controlled, phase 3 study to evaluate the efficacy, safety, and tolerability of JNJ-27018966 in the treatment of patients with Diarrhea-Predominant Irritable Bowel Syndrome.

Inclusion Criteria:

1. Patient is a man or woman aged 18 to 80 years, inclusive, at prescreening.

2. Patient has a diagnosis of IBS with a subtype of diarrhea defined by the Rome III criteria as loose (mushy) or watery stools ≥25% and hard or lumpy stools <25% of bowel movements (see Appendix 6.2: Rome III Diagnostic Criteria for IBS for a definition of IBS and subtyping by predominant stool pattern).

3. Patient has had a colonoscopy performed within 5 years prior to prescreening if they are at least 50 years of age OR if any of the following alarm features are met:

  • Patient has documented weight loss within the past 6 months
  • Patient has nocturnal symptoms
  • Patient has a familial history of colon cancer, or
  • Patient has blood mixed with their stool (excluding any blood from hemorrhoids)


Qualified Participants May Receive:

$600.00.


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.